| Purpose: By observing Zibuliangxue treatment of chronic glomerulonephritis hematuria (Syndromeof deficiency of both qi and yin) therapeutic effect. Comparing all the inspection data before and aftermedication and the improvement of symptoms and signs. To verify that the Zibuliangxue clinical safety andefficacy, to provide basis for clinical medication.Method: Regions in Jilin province people’s hospital of the patients, In chronic glomerular nephritishematuria (qi and Yin deficiency syndrome) of60patients with clinical diagnosis standard, were randomlydivided into2groups, the treatment group and control group30cases each. in addition to the foundationtreatment, treatment group given Zibuliangxue oral, the control group given nephritis rehabilitation oral,four weeks after observing two groups of patients with clinical symptoms and signs of change, Comparedbefore and after treatment in all kinds of test results.Result: Zibuliangxue group recovered in2cases (6.67%),15cases were markedly improved (50%),effective9cases (30%),4cases were ineffective (13.3%),the total effective rate was86.67%;Shenyankangfu tablets were cured1case (13.33%) were cured,,15cases were markedly improved (50%),8cases (26.67%), effective invalid6cases (20%), the total effective rate80.00%. Through the statistical test,two efficient and clinically significant overall efficiency by statistically (P>0.05), no difference. But for theweakness of shortness of breath, dry mouth, eat to reduce the improvement of clinical symptoms, throughthe comparison between groups, the difference was statistically significant (P <0.05), shows that curativeeffect in the treatment group was obviously better than the control group.Conclusion: Zibuliangxue has better clinical curative effect, can improve chronic glomerularnephritis hematuria (qi and Yin deficiency syndrome) in patients with clinical symptoms, reduce blood inthe urine, and did not appear any side effects and adverse reactions in clinical research. |